De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Repligen Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Repligen heeft een totaal eigen vermogen van $2.0B en een totale schuld van $587.2M, wat de schuld-eigenvermogensverhouding op 29.6% brengt. De totale activa en totale passiva bedragen respectievelijk $2.9B en $875.6M. De EBIT Repligen is $8.4M waardoor de rentedekking -0.7 is. Het heeft contanten en kortetermijnbeleggingen van $809.1M.
Belangrijke informatie
29.6%
Verhouding schuld/eigen vermogen
US$587.21m
Schuld
| Rente dekkingsratio | -0.7x |
| Contant | US$809.15m |
| Aandelen | US$1.99b |
| Totaal verplichtingen | US$875.56m |
| Totaal activa | US$2.86b |
Recente financiële gezondheidsupdates
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly
Apr 11Recent updates
Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
May 23Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly
Apr 11Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?
Mar 28We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease
Mar 08Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.2B ) RGEN } overtreffen de korte termijn passiva ( $174.3M ).
Langlopende schulden: De kortetermijnactiva RGEN ( $1.2B ) overtreffen de langetermijnschulden ( $701.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: RGEN heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van RGEN is de afgelopen 5 jaar gestegen van 12% naar 29.6%.
Schuldendekking: De schuld van RGEN wordt goed gedekt door de operationele kasstroom ( 26.4% ).
Rentedekking: RGEN verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.